dgkh000227
10.3205/dgkh000227
urn:nbn:de:0183-dgkh0002273
Research Article
First report of OXA-48-producing Klebsiella pneumoniae strains in Iran
Erstbeschreibung von OXA-48-produzierenden Klebsiella pneumoniae-Stämmen im Iran
Azimi
Azimi
Leila
L
Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran
author
Nordmann
Nordmann
Patrice
P
INSERM U914, Le Kremlin-Bicêtre, France
author
Lari
Lari
Abdolaziz Rastegar
AR
PhD
Clinical Microbiology, Iran University of Medical Sciences, P.O. Box 14515-717, Tehran, Iran, Phone/Fax: +98 21 86703183Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, IranDepartment of Microbiology, Iran University of Medical Sciences, Tehran, Iran
azizlari@gmail.com
author
Bonnin
Bonnin
Rémy A.
RA
INSERM U914, Le Kremlin-Bicêtre, France
author
German Medical Science GMS Publishing House
Düsseldorf
610
carbapenem
Klebsiella pneumoniae
CarbaNP test
MHT
OXA-48
20140307
engl
2196-5226
9
1
GMS Hygiene and Infection Control
GMS Hyg Infect Control
07
Iran University of Medical Sciences
Carbapenem-resistente Enterobacteriaceae sind weltweit ein zunehmendes therapeutisches Problem in Einrichtungen des Gesundheitswesens. In dieser epidemiologischen Untersuchung wurden 28 Imipenem-resistente K. pneumoniae-Stämme aus klinischem Material phenotypisch und genotypisch gegenüber ihrer Expression von Carbapenemasen untersucht. Carbapenemase-Bildung wurde phenotypisch mittels eines modifizierten Hodge-Tests (MHT) und eines CarbaNP-Tests und genotypisch mittels PCR unter Verwendung spezifischer Primer zur Detektion von Carbapenemase-Genen der Typen blaOXA-48, blaKPC, blaNDM and blaVIM analysiert. MHT- und CarbaNP-Tests waren bei allen untersuchten Imipenem-resistenten K. pneumoniae-Stämmen positiv. Das blaOXA-48-Gen wurde in 27/28 Isolaten nachgewiesen. Bei einem Isolat wurde das blaVIM-4-Gen nachgewiesen. Basierend auf dieser Untersuchung zeigten der NP-Test und der MHT die höchste Sensitivität und Spezifität zum Nachweis des Carbapenemase-Status. Diese Studie ist der erste Bericht über das Vorkommen von OXA-48-produzierenden K. pneumoniae-Stämmen im Iran.
Carbapenem-resistant Enterobacteriaceae are increasingly reported worldwide and cause therapeutic problem in health care facilities. In this study 28 imipenem-resistant K. pneumoniae were examined for expression of carbapenemases by phenotypic and genotypic methods. Modified Hodge Test (MHT), CarbaNP test were used for phenotypic detection, and PCR using specific primers for the detection of blaOXA-48-, blaKPC-, blaNDM- and blaVIM-type carbapenemases with specific primers were performed. MHT and CarbaNP tests were positive for all of imipenem-resistant K. pneumoniae. The blaOXA-48 gene was detected in 27/28 isolates. One isolate was positive for the presence of the blaVIM-4 gene. According to our results NP test and MHT have high sensitivity and specificity for detection of those carbapenemases. This study reports the first cases of OXA-48-producing K. pneumoniae in Iran.
IntroductionCarbapenems are often considered as a last therapeutic choice for the treatment of infections due to multidrug-resistant Gram-negative rods , , , , . Emergence of carbapenem-resistant Enterobacteriaceae is increasingly reported worldwide and is becoming an important issue in health care systems , . Resistance to carbapenems in K. pneumoniae is related to two main mechanisms: i) production of extended-spectrum <![CDATA[β-lactamase</PlainText></TextGroup> (cephalosporinase or ESBL) associated with porin loss, and ii) production of carbapenem-hydrolyzing β-lactamase such as Ambler’s class A carbapenemases (KPC-type), class B metallo-β-lactamase (VIM-, NDM- or IMP-type) or class D carbapenemase OXA-48 <TextLink reference="1"></TextLink>, <TextLink reference="4"></TextLink>, <TextLink reference="6"></TextLink>, <TextLink reference="7"></TextLink>. A number of phenotypical methods were used for detection of carbapenemases producer strains such as Modified Hodge Test (MHT) according to CLSI recommendations <TextLink reference="8"></TextLink>. One new phenotypic method was described for detection of carbapenemases producer bacteria <TextLink reference="1"></TextLink>. This test is currently utilized to identify the carbapenemase production in Gram-negative bacteria, with a low cost and high sensitivity and specificity, and was performed for rapid detection (≤2 h) of carbapenemases <TextLink reference="1"></TextLink>, <TextLink reference="2"></TextLink>. CarbaNP test is a biochemical test, applicable to isolated bacterial colonies, and is based on in vitro hydrolysis of a carbapenem compound (imipenem). The OXA-48 carbapenemase was first reported from a Turkish isolates in 2004 <TextLink reference="7"></TextLink> but recently the OXA-48-producing <Mark2>Enterobacteriaceae</Mark2> is repeatedly reported from different parts of the world however mostly from Mediterranean countries <TextLink reference="9"></TextLink>. The <Mark2>bla</Mark2><Mark2><Subscript>OXA-48</Subscript></Mark2> has been identified within the Tn1999 composite transposon bracketed by two copies of IS1999 responsible for its mobility and expression <TextLink reference="10"></TextLink>, <TextLink reference="11"></TextLink>. This carbapenemase gene is harbored by an IncL/M-type plasmid in which the Tn1999 was inserted <TextLink reference="12"></TextLink>. This highly conjugative plasmid has been found responsible for the widespread of the <Mark2>bla</Mark2><Mark2><Subscript>OXA-48</Subscript></Mark2> genes <TextLink reference="12"></TextLink>. </Pgraph><Pgraph>The <Mark2>bla</Mark2><Mark2><Subscript>OXA-48</Subscript></Mark2> gene is spreading worldwide but not yet reported from Iran. In this study, we report the very first cases of OXA-48-producing <Mark2>K. pneumoniae</Mark2> identified in Iran.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Methods">
<MainHeadline>Methods</MainHeadline><SubHeadline>Bacterial strains and susceptibility testings </SubHeadline><Pgraph>In this study, a collection of 28 non-duplicated carbapenem-resistant <Mark2>K. pneumoniae</Mark2> isolated from 18 patients has been analyzed. All of these invasive strains were obtained from clinical specimens taken from patients hospitalized in a burn unit from Motahari Hospital, Teheran, Iran between February to August 2011. More than one <Mark2>K. pneumonia</Mark2> strain was isolated from 10 patients, but different antibiograms were observed in these isolates. On the other hand different specimens were collected from patients in different days after their hospitalization. </Pgraph><Pgraph>All of these 28 strains were isolated from infected burn wounds. Fifteen patients received meropenem as monotherapy whereas the three remaining patients received cefepime as monotherapy. </Pgraph><Pgraph>These strains were isolated from wounds of burn patients hospitalized in Motahari Hospital (referral center for burn patients in Tehran, Iran) from February to August 2011. These isolates were identified by using the API 20E system (bioMérieux, Marcy l’Etoile, France).</Pgraph><SubHeadline>Antibiotic susceptibility testing</SubHeadline><Pgraph>The antibiotic susceptibilities of the isolates were determined by the agar disc diffusion method on Mueller-Hinton agar with antibiotic discs MAST Company, UK and interpreted according to Clinical and Laboratory Standards Institute CLSI guidelines <TextLink reference="8"></TextLink>. Tested antibiotics included; cefotaxime (30 µg), cefepime (30 µg), imipenem (10 µg), meropenem (10 µg), amoxicillin-clavulanic acid (<TextGroup><PlainText>20/10 µg</PlainText></TextGroup>), aztreonam (30 µg), tobramycin (10 µg), gentamicin (10 µg), amikacin (30 µg), trimethoprim-sulfamethoxazole (1.25/23.75 μg), chloramphenicol (<TextGroup><PlainText>30 µg</PlainText></TextGroup>) and tetracycline (30 µg). MIC of imipenem, meropenem and cefepime were determined by agar dilution method. </Pgraph><SubHeadline>Phenotypic methods for detection of carbapenemase</SubHeadline><Pgraph><Mark1>Modified Hodge Test (MHT):</Mark1> This test was conducted according to the CLSI 2011 guidelines for search of carbapenemase production [8]. <Mark2>K. pneumoniae</Mark2> ATCC BAA-1705 were used as positive and <Mark2>K. pneumoniae</Mark2> ATCC BAA-1706 as negative controls. Strains with cloverleaf images of inhibition zone were considered as a carbapenemase-producing <Mark2>K. pneumoniae</Mark2>.</Pgraph><Pgraph><Mark1>Use of boronic acid as a KPC inhibitor:</Mark1> Use of boronic acid (BA) as an inhibitor of KPC in combined-disk test with 400 µg/disc BA was carried out. </Pgraph><Pgraph>The stock solution of BA (benzene boronic acid; Sigma-Alderich, Germany) in dimethyl sulfoxcid and distilled water were mixed at a concentration of 20 mg/ml. From this solution 20 µl (containing 400 µg/disk) was added on to commercially meropenem disks. </Pgraph><Pgraph>The test was considered positive when the inhibition zone diameter around the disk containing meropenem and boronic acid was ≥5 mm compared with meropenem alone.</Pgraph><Pgraph> </Pgraph><Pgraph><Mark1>CarbaNP test (Carbapenemase Nordmann-Poirel test):</Mark1> One loop of strains was resuspended to Tris-HCL mmol/L as a lysis buffer from antibiogram plates, vortex for one minute and then incubated at room temperature for <TextGroup><PlainText>30 m</PlainText></TextGroup>inutes. Bacterial suspension was centrifuged at <TextGroup><PlainText>10,000 xg</PlainText></TextGroup> at room temperature for 5 minutes. 30 µl of supernatant was mixed in 96 tray with 100 µl of imipenem monohydrate solusion (3 mg per ml) pH 7.8, phenolred solution and 0.1 mmol/L ZnSO<Subscript>4</Subscript>. </Pgraph><SubHeadline>PCR amplification and sequencing</SubHeadline><Pgraph>Rapid DNA extractions were prepared by boiling extraction. PCR experiments were performed using standard conditions and specific primers to search for carbapenemase genes that have been identified previously in <Mark2>K. pneumoniae</Mark2> i.e. the <Mark2>bla</Mark2><Mark2><Subscript>VIM</Subscript></Mark2>, <Mark2>bla</Mark2><Mark2><Subscript>IMP</Subscript></Mark2>, <Mark2>bla</Mark2><Mark2><Subscript>NDM</Subscript></Mark2>, <Mark2>bla</Mark2><Mark2><Subscript>KPC</Subscript></Mark2> and <Mark2>bla</Mark2><Mark2><Subscript>OXA-4</Subscript></Mark2><Subscript>8</Subscript> (Table 1 <ImgLink imgNo="1" imgType="table"/>). Direct sequencing of PCR amplified products was carried out using ABI 3730X capillary sequencer (Genfanavaran, Macrogen, Seoul, Korea).</Pgraph></TextBlock>
<TextBlock linked="yes" name="Results">
<MainHeadline>Results</MainHeadline><Pgraph>Among these 28 isolates, all were resistant to broad-spectrum cephalosporins, carbapenems (imipenem, ertapenem, meropenem), trimethoprim-sulfamethoxazole and quinolones (Table 2 <ImgLink imgNo="2" imgType="table"/>). Some of them remained susceptible to amikacin and/or gentamicin, respectively (resistance rates for gentamicin at 90% and resistance rates to chloramphenicol, tetracycline and amikacin at 82%, 86% and 79%, respectively). Antimicrobial susceptibility testing results showed that all of the strains were resistant to imipenem, meropenem, and cefepime. Nine and eleven out of 28 isolates had MIC more than 64 µg/ml against imipenem and meropenem, respectively. Nineteen of <TextGroup><PlainText>28 s</PlainText></TextGroup>trains had MIC more than 128 µg/ml against cefepime. </Pgraph><Pgraph>Eight different antimicrobial resistant patterns were observed among isolates likely indicating several clone are disseminating within the burn unit (Table 2 <ImgLink imgNo="2" imgType="table"/>). The results show that MHT and CarbaNP tests were positive for all carbapenem-resistant <Mark2>K. pneumoniae</Mark2> but none of them showed at least 5 mm increase in diameter of inhibition zone around meropenem plus BA comparison with meropenem alone.</Pgraph><Pgraph>PCR analysis following by sequencing showed the presence of the <Mark2>bla</Mark2><Mark2><Subscript>OXA-48</Subscript></Mark2> gene in 27 isolates (Figure 1 <ImgLink imgNo="1" imgType="figure"/>). </Pgraph><Pgraph>Whereas a single isolate was positive for <Mark2>bla</Mark2><Mark2><Subscript>VIM-4</Subscript></Mark2> gene. No <Mark2>bla</Mark2><Mark2><Subscript>KPC</Subscript></Mark2>, <Mark2>bla</Mark2><Mark2><Subscript>NDM</Subscript></Mark2> or <Mark2>bla</Mark2><Mark2><Subscript>IMP</Subscript></Mark2> genes were detected in this collection.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Discussion">
<MainHeadline>Discussion</MainHeadline><Pgraph>Different <Mark2>K. pneumionieae</Mark2> with different antibiograms were isolated from one patient. Despite the <Mark2>K. pneumonia</Mark2> were isolated with same antibiogram among different patients. Isolates with same antibiotic-resistant pattern may derive from identical clone. </Pgraph><Pgraph>The OXA-48-type carbapenemases have been reported from France <TextLink reference="4"></TextLink>, Spain <TextLink reference="6"></TextLink>, Netherlands <TextLink reference="13"></TextLink>, Lebanon <TextLink reference="4"></TextLink>, Morocco <TextLink reference="14"></TextLink> and Oman <TextLink reference="15"></TextLink> and is becoming one of the main resistance mechanisms in <Mark2>K. pneumoniae</Mark2> <TextLink reference="10"></TextLink>. The <Mark2>bla</Mark2><Mark2><Subscript>OXA-48</Subscript></Mark2> gene has been identified in 90.5% of <TextGroup><Mark2>K. pneumoniae</Mark2></TextGroup> isolates in six different Spanish hospitals <TextLink reference="6"></TextLink>. To best of our knowledge, this study constitutes the very first report of OXA-48-producing <Mark2>K. pneumoniae</Mark2> from Iran. Detection of OXA-48-producing <Mark2>Enterobacteriaceae</Mark2> can be important, because such strains may often remain susceptible to third and fourth generation cephalosporins and monobactams and also this characteristic can make difficulty for detection of them <TextLink reference="10"></TextLink>. After the recent identification of the <Mark2>bla</Mark2><Mark2><Subscript>KPC</Subscript></Mark2> and the <Mark2>bla</Mark2><Mark2><Subscript>NDM-1</Subscript></Mark2> genes in a burn unit in Teheran, the identification of the <Mark2>bla</Mark2><Mark2><Subscript>OXA-48</Subscript></Mark2> carbapenemase gene is worrisome <TextLink reference="5"></TextLink>, <TextLink reference="16"></TextLink>.</Pgraph><Pgraph>Overall, this study identifies for the first time OXA-48-producing <Mark2>K. pneumoniae</Mark2> strains from Iran. Therefore, the spread of OXA-48 producers may be more widespread than expected and can be expected in any countries of the Middle East.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Notes">
<MainHeadline>Notes</MainHeadline><SubHeadline>Competing interests</SubHeadline><Pgraph>The authors declare that they have no competing interests.</Pgraph><SubHeadline>Acknowledgment </SubHeadline><Pgraph>This study was supported by a grant (M/T 91-04-134-20187) from Iran University of Medical Sciences, Tehran, Iran.</Pgraph></TextBlock>
<References linked="yes">
<Reference refNo="1">
<RefAuthor>Nordmann P</RefAuthor>
<RefAuthor>Poirel L</RefAuthor>
<RefAuthor>Dortet L</RefAuthor>
<RefTitle>Rapid detection of carbapenemase-producing Enterobacteriaceae</RefTitle>
<RefYear>2012</RefYear>
<RefJournal>Emerging Infect Dis</RefJournal>
<RefPage>1503-7</RefPage>
<RefTotal>Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerging Infect Dis. 2012 Sep;18(9):1503-7. DOI: 10.3201/eid1809.120355</RefTotal>
<RefLink>http://dx.doi.org/10.3201/eid1809.120355</RefLink>
</Reference>
<Reference refNo="2">
<RefAuthor>Nordmann P</RefAuthor>
<RefAuthor>Poirel L</RefAuthor>
<RefTitle>Strategies for identification of carbapenemase-producing Enterobacteriaceae</RefTitle>
<RefYear>2013</RefYear>
<RefJournal>J Antimicrob Chemother</RefJournal>
<RefPage>487-9</RefPage>
<RefTotal>Nordmann P, Poirel L. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2013 Mar;68(3):487-9. DOI: 10.1093/jac/dks426</RefTotal>
<RefLink>http://dx.doi.org/10.1093/jac/dks426</RefLink>
</Reference>
<Reference refNo="3">
<RefAuthor>Navarro-San Francisco C</RefAuthor>
<RefAuthor>Mora-Rillo M</RefAuthor>
<RefAuthor>Romero-Gomez MP</RefAuthor>
<RefAuthor>Moreno-Ramos F</RefAuthor>
<RefAuthor>Rico-Nieto A</RefAuthor>
<RefAuthor>Ruiz-Carrascoso G</RefAuthor>
<RefAuthor>Gomez-Gil R</RefAuthor>
<RefAuthor>Arribas-Lopez JR</RefAuthor>
<RefAuthor>Mingorance J</RefAuthor>
<RefAuthor>Pano-Pardo J</RefAuthor>
<RefTitle>Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge</RefTitle>
<RefYear>2013</RefYear>
<RefJournal>Clin Microbiol Infect</RefJournal>
<RefPage>E72-9</RefPage>
<RefTotal>Navarro-San Francisco C, Mora-Rillo M, Romero-Gomez MP, Moreno-Ramos F, Rico-Nieto A, Ruiz-Carrascoso G, Gomez-Gil R, Arribas-Lopez JR, Mingorance J, Pano-Pardo J. Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge. Clin Microbiol Infect. 2013;19:E72-9. DOI: 10.1111/1469-069.12091</RefTotal>
<RefLink>http://dx.doi.org/10.1111/1469-069.12091</RefLink>
</Reference>
<Reference refNo="4">
<RefAuthor>Cuzon G</RefAuthor>
<RefAuthor>Ouanich J</RefAuthor>
<RefAuthor>Gondret R</RefAuthor>
<RefAuthor>Naas T</RefAuthor>
<RefAuthor>Nordmann P</RefAuthor>
<RefTitle>Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France</RefTitle>
<RefYear>2011</RefYear>
<RefJournal>Antimicrob Agents Chemother</RefJournal>
<RefPage>2420-3</RefPage>
<RefTotal>Cuzon G, Ouanich J, Gondret R, Naas T, Nordmann P. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother. 2011 May;55(5):2420-3. DOI: 10.1128/AAC.01452-10</RefTotal>
<RefLink>http://dx.doi.org/10.1128/AAC.01452-10</RefLink>
</Reference>
<Reference refNo="5">
<RefAuthor>Rastegar Lari A</RefAuthor>
<RefAuthor>Azimi L</RefAuthor>
<RefAuthor>Rahbar M</RefAuthor>
<RefAuthor>Fallah F</RefAuthor>
<RefAuthor>Alaghehbandan R</RefAuthor>
<RefTitle>Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: first report from Iran</RefTitle>
<RefYear>2013</RefYear>
<RefJournal>Burns</RefJournal>
<RefPage>174-6</RefPage>
<RefTotal>Rastegar Lari A, Azimi L, Rahbar M, Fallah F, Alaghehbandan R. Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: first report from Iran. Burns. 2013 Feb;39(1):174-6. DOI: 10.1016/j.burns.2012.02.025</RefTotal>
<RefLink>http://dx.doi.org/10.1016/j.burns.2012.02.025</RefLink>
</Reference>
<Reference refNo="6">
<RefAuthor>Oteo J</RefAuthor>
<RefAuthor>Hernández JM</RefAuthor>
<RefAuthor>Espasa M</RefAuthor>
<RefAuthor>Fleites A</RefAuthor>
<RefAuthor>Sáez D</RefAuthor>
<RefAuthor>Bautista V</RefAuthor>
<RefAuthor>Pérez-Vázquez M</RefAuthor>
<RefAuthor>Fernández-García MD</RefAuthor>
<RefAuthor>Delgado-Iribarren A</RefAuthor>
<RefAuthor>Sánchez-Romero I</RefAuthor>
<RefAuthor>García-Picazo L</RefAuthor>
<RefAuthor>Miguel MD</RefAuthor>
<RefAuthor>Solís S</RefAuthor>
<RefAuthor>Aznar E</RefAuthor>
<RefAuthor>Trujillo G</RefAuthor>
<RefAuthor>Mediavilla C</RefAuthor>
<RefAuthor>Fontanals D</RefAuthor>
<RefAuthor>Rojo S</RefAuthor>
<RefAuthor>Vindel A</RefAuthor>
<RefAuthor>Campos J</RefAuthor>
<RefTitle>Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain</RefTitle>
<RefYear>2013</RefYear>
<RefJournal>J Antimicrob Chemother</RefJournal>
<RefPage>317-21</RefPage>
<RefTotal>Oteo J, Hernández JM, Espasa M, Fleites A, Sáez D, Bautista V, Pérez-Vázquez M, Fernández-García MD, Delgado-Iribarren A, Sánchez-Romero I, García-Picazo L, Miguel MD, Solís S, Aznar E, Trujillo G, Mediavilla C, Fontanals D, Rojo S, Vindel A, Campos J. Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain. J Antimicrob Chemother. 2013 Feb;68(2):317-21. DOI: 10.1093/jac/dks383</RefTotal>
<RefLink>http://dx.doi.org/10.1093/jac/dks383</RefLink>
</Reference>
<Reference refNo="7">
<RefAuthor>Carrër A</RefAuthor>
<RefAuthor>Poirel L</RefAuthor>
<RefAuthor>Eraksoy H</RefAuthor>
<RefAuthor>Cagatay AA</RefAuthor>
<RefAuthor>Badur S</RefAuthor>
<RefAuthor>Nordmann P</RefAuthor>
<RefTitle>Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey</RefTitle>
<RefYear>2008</RefYear>
<RefJournal>Antimicrob Agents Chemother</RefJournal>
<RefPage>2950-4</RefPage>
<RefTotal>Carrër A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother. 2008 Aug;52(8):2950-4. DOI: 10.1128/AAC.01672-07</RefTotal>
<RefLink>http://dx.doi.org/10.1128/AAC.01672-07</RefLink>
</Reference>
<Reference refNo="8">
<RefAuthor>Clinical and Laboratory Standards Institute (CLSI)</RefAuthor>
<RefTitle></RefTitle>
<RefYear>2011</RefYear>
<RefBookTitle>Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement. M100-S21</RefBookTitle>
<RefPage></RefPage>
<RefTotal>Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement. M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.</RefTotal>
</Reference>
<Reference refNo="9">
<RefAuthor>Poirel L</RefAuthor>
<RefAuthor>Potron A</RefAuthor>
<RefAuthor>Nordmann P</RefAuthor>
<RefTitle>OXA-48-like carbapenemases: the phantom menace</RefTitle>
<RefYear>2012</RefYear>
<RefJournal>J Antimicrob Chemother</RefJournal>
<RefPage>1597-606</RefPage>
<RefTotal>Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012 Jul;67(7):1597-606. DOI: 10.1093/jac/dks121</RefTotal>
<RefLink>http://dx.doi.org/10.1093/jac/dks121</RefLink>
</Reference>
<Reference refNo="10">
<RefAuthor>Poirel L</RefAuthor>
<RefAuthor>Héritier C</RefAuthor>
<RefAuthor>Tolün V</RefAuthor>
<RefAuthor>Nordmann P</RefAuthor>
<RefTitle>Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumonia</RefTitle>
<RefYear>2004</RefYear>
<RefJournal>Antimicrob Agents Chemother</RefJournal>
<RefPage>15-22</RefPage>
<RefTotal>Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumonia. Antimicrob Agents Chemother. 2004;8:15-22. DOI: 10.1128/AAC.48.1.15-22.2004</RefTotal>
<RefLink>http://dx.doi.org/10.1128/AAC.48.1.15-22.2004</RefLink>
</Reference>
<Reference refNo="11">
<RefAuthor>Aubert D</RefAuthor>
<RefAuthor>Naas T</RefAuthor>
<RefAuthor>Héritier C</RefAuthor>
<RefAuthor>Poirel L</RefAuthor>
<RefAuthor>Nordmann P</RefAuthor>
<RefTitle>Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of beta-lactam resistance genes</RefTitle>
<RefYear>2006</RefYear>
<RefJournal>J Bacteriol</RefJournal>
<RefPage>6506-14</RefPage>
<RefTotal>Aubert D, Naas T, Héritier C, Poirel L, Nordmann P. Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of beta-lactam resistance genes. J Bacteriol. 2006 Sep;188(18):6506-14. DOI: 10.1128/JB.00375-06</RefTotal>
<RefLink>http://dx.doi.org/10.1128/JB.00375-06</RefLink>
</Reference>
<Reference refNo="12">
<RefAuthor>Poirel L</RefAuthor>
<RefAuthor>Bonnin RA</RefAuthor>
<RefAuthor>Nordmann P</RefAuthor>
<RefTitle>Genetic features of the widespread plasmid coding for the carbapenemase OXA-48</RefTitle>
<RefYear>2012</RefYear>
<RefJournal>Antimicrob Agents Chemother</RefJournal>
<RefPage>559-62</RefPage>
<RefTotal>Poirel L, Bonnin RA, Nordmann P. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother. 2012 Jan;56(1):559-62. DOI: 10.1128/AAC.05289-11</RefTotal>
<RefLink>http://dx.doi.org/10.1128/AAC.05289-11</RefLink>
</Reference>
<Reference refNo="17">
<RefAuthor>Voets GM</RefAuthor>
<RefAuthor>Fluit AC</RefAuthor>
<RefAuthor>Scharringa J</RefAuthor>
<RefAuthor>Cohen Stuart J</RefAuthor>
<RefAuthor>Leverstein-van Hall MA</RefAuthor>
<RefTitle>A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases</RefTitle>
<RefYear>2011</RefYear>
<RefJournal>Int J Antimicrob Agents</RefJournal>
<RefPage>356-9</RefPage>
<RefTotal>Voets GM, Fluit AC, Scharringa J, Cohen Stuart J, Leverstein-van Hall MA. A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases. Int J Antimicrob Agents. 2011 Apr;37(4):356-9. DOI: 10.1016/j.ijantimicag.2011.01.005</RefTotal>
<RefLink>http://dx.doi.org/10.1016/j.ijantimicag.2011.01.005</RefLink>
</Reference>
<Reference refNo="18">
<RefAuthor>Naas T</RefAuthor>
<RefAuthor>Cuzon G</RefAuthor>
<RefAuthor>Villegas MV</RefAuthor>
<RefAuthor>Lartigue MF</RefAuthor>
<RefAuthor>Quinn JP</RefAuthor>
<RefAuthor>Nordmann P</RefAuthor>
<RefTitle>Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene</RefTitle>
<RefYear>2008</RefYear>
<RefJournal>Antimicrob Agents Chemother</RefJournal>
<RefPage>1257-63</RefPage>
<RefTotal>Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene. Antimicrob Agents Chemother. 2008 Apr;52(4):1257-63. DOI: 10.1128/AAC.01451-07</RefTotal>
<RefLink>http://dx.doi.org/10.1128/AAC.01451-07</RefLink>
</Reference>
<Reference refNo="13">
<RefAuthor>Potron A</RefAuthor>
<RefAuthor>Kalpoe J</RefAuthor>
<RefAuthor>Poirel L</RefAuthor>
<RefAuthor>Nordmann P</RefAuthor>
<RefTitle>European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone</RefTitle>
<RefYear>2011</RefYear>
<RefJournal>Clin Microbiol Infect</RefJournal>
<RefPage>E24-6</RefPage>
<RefTotal>Potron A, Kalpoe J, Poirel L, Nordmann P. European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone. Clin Microbiol Infect. 2011 Dec;17(12):E24-6. DOI: 10.1111/j.1469-0691.2011.03669.x</RefTotal>
<RefLink>http://dx.doi.org/10.1111/j.1469-0691.2011.03669.x</RefLink>
</Reference>
<Reference refNo="14">
<RefAuthor>Hays C</RefAuthor>
<RefAuthor>Benouda A</RefAuthor>
<RefAuthor>Poirel L</RefAuthor>
<RefAuthor>Elouennass M</RefAuthor>
<RefAuthor>Nordmann O</RefAuthor>
<RefTitle>Nosocomial occurrence of OXA-48-producing enterobacterial isolates in a Moroccan hospital</RefTitle>
<RefYear>2012</RefYear>
<RefJournal>Int J Antimicrob Agents</RefJournal>
<RefPage>545-7</RefPage>
<RefTotal>Hays C, Benouda A, Poirel L, Elouennass M, Nordmann O. Nosocomial occurrence of OXA-48-producing enterobacterial isolates in a Moroccan hospital. Int J Antimicrob Agents. 2012;39:545-7. DOI: 10.1016/j.ijantimicag.2012.03.002</RefTotal>
<RefLink>http://dx.doi.org/10.1016/j.ijantimicag.2012.03.002</RefLink>
</Reference>
<Reference refNo="15">
<RefAuthor>Dortet L</RefAuthor>
<RefAuthor>Poirel L</RefAuthor>
<RefAuthor>Al Yaqoubi F</RefAuthor>
<RefAuthor>Nordmann P</RefAuthor>
<RefTitle>NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman</RefTitle>
<RefYear>2012</RefYear>
<RefJournal>Clin Microbiol Infect</RefJournal>
<RefPage>E144-8</RefPage>
<RefTotal>Dortet L, Poirel L, Al Yaqoubi F, Nordmann P. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. Clin Microbiol Infect. 2012 May;18(5):E144-8. DOI: 10.1111/j.1469-0691.2012.03796.x</RefTotal>
<RefLink>http://dx.doi.org/10.1111/j.1469-0691.2012.03796.x</RefLink>
</Reference>
<Reference refNo="16">
<RefAuthor>Shahcheraghi F</RefAuthor>
<RefAuthor>Nobari S</RefAuthor>
<RefAuthor>Rahmati Ghezelgeh F</RefAuthor>
<RefAuthor>Nasiri S</RefAuthor>
<RefAuthor>Owlia P</RefAuthor>
<RefAuthor>Nikbin VS</RefAuthor>
<RefAuthor>Imani Fooladi AA</RefAuthor>
<RefTitle>First report of New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae in Iran</RefTitle>
<RefYear>2013</RefYear>
<RefJournal>Microb Drug Resist</RefJournal>
<RefPage>30-6</RefPage>
<RefTotal>Shahcheraghi F, Nobari S, Rahmati Ghezelgeh F, Nasiri S, Owlia P, Nikbin VS, Imani Fooladi AA. First report of New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae in Iran. Microb Drug Resist. 2013 Feb;19(1):30-6. DOI: 10.1089/mdr.2012.0078</RefTotal>
<RefLink>http://dx.doi.org/10.1089/mdr.2012.0078</RefLink>
</Reference>
</References>
<Media>
<Tables>
<Table format="png">
<MediaNo>1</MediaNo>
<MediaID>1</MediaID>
<Caption><Pgraph><Mark1>Table 1: Primers sequencing</Mark1></Pgraph></Caption>
</Table>
<Table format="png">
<MediaNo>2</MediaNo>
<MediaID>2</MediaID>
<Caption><Pgraph><Mark1>Table 2: Antibiotic susceptibility patterns</Mark1></Pgraph></Caption>
</Table>
<NoOfTables>2</NoOfTables>
</Tables>
<Figures>
<Figure format="png" height="231" width="535">
<MediaNo>1</MediaNo>
<MediaID>1</MediaID>
<Caption><Pgraph><Mark1>Figure 1: PCR amplification fragments for detection of OXA-48 gene among </Mark1><Mark1><Mark2>Klebsiella pneumoniae</Mark2></Mark1><Mark1> isolates </Mark1><LineBreak></LineBreak>M: 1kb DNA size marker; lane 1: Positive control; lane 2 and 3: Positive strains.</Pgraph></Caption>
</Figure>
<NoOfPictures>1</NoOfPictures>
</Figures>
<InlineFigures>
<NoOfPictures>0</NoOfPictures>
</InlineFigures>
<Attachments>
<NoOfAttachments>0</NoOfAttachments>
</Attachments>
</Media>
</OrigData>
</GmsArticle>]]></plaintext></textgroup></pgraph></textblock></origdata></gmsarticle>